With a strong scientific-phase pipeline, Agenus harnesses a mix of proprietary antibody platforms, which include Retrocyte Display™ and SECANT®, and progressive cell therapy approaches, positioning alone for a critical contributor while in the biotechnology and immunotherapy arena.These built-in technologies let for the event of each solitary-ag